Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tildrakizumab in Moderate-to-Severe Plaque Psoriasis (China, Phase III)
CTR20201837Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Sep 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tildrakizumab in psoriasis, sponsored by Sun Pharma. Started Sep 2020; status: completed.
02
Drugs
tildrakizumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20201837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201837.